Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the multivalent vaccines market grown over the years?

The multivalent vaccines market has grown steadily, expected to increase from $8.37 billion in 2024 to $9.2 billion in 2025, at a CAGR of 10.0%. Growth is attributed to rising public awareness about vaccination, greater government support, increasing demand for pediatric multivalent vaccines, expanded funding for vaccine research, and higher demand for multi-disease protection.

What Is the forecasted market size and growth rate for the multivalent vaccines market?

The multivalent vaccines market is projected to grow significantly, reaching $13.32 billion by 2029 at a CAGR of 9.7%. Growth factors include the increasing prevalence of infectious diseases, a rising geriatric population, greater government and private sector investments, enhanced vaccine safety focus, and increased interest in therapeutic vaccines. Key trends include the development of combination vaccines, digital health technology integration, advancements in mRNA technology, personalized vaccine innovations, and expanding research activities.

Get your multivalent vaccines market report here!

https://www.thebusinessresearchcompany.com/report/multivalent-vaccines-global-market-report

What are the major factors driving growth in the multivalent vaccines market?

The growing incidences of infectious diseases are expected to drive the multivalent vaccines market. Infectious diseases, caused by pathogens such as bacteria and viruses, are spreading faster due to global travel. Multivalent vaccines offer broader protection by targeting multiple pathogen strains in a single dose. In April 2024, TravelHealthPro reported an increase in malaria cases in the UK, emphasizing the need for multivalent vaccines to combat infectious diseases.

What key areas define the segmentation of the global multivalent vaccines Market?

The multivalent vaccinesmarket covered in this report is segmented –

1) By Type: Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines

2) By Disease: Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus

3) By Route Of Administration: Oral, Injectable

4) By Age Group: Pediatrics, Adults, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines, Protein Conjugate Vaccines

2) By Inactivated And Subunit Vaccines: Inactivated Whole Virus Vaccines, Subunit Protein Vaccines, Virus-Like Particle Vaccines

3) By Live Attenuated Vaccines: Live Attenuated Bacterial Vaccines, Live Attenuated Viral Vaccines

4) By Toxoid Vaccines: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

5) By Recombinant Vaccines: Recombinant Protein Vaccines, Recombinant DNA Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19120&type=smp

What are the top market players propelling the growth of the multivalent vaccines industry?

Major companies operating in the multivalent vaccines market are Pfizer Inc., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Moderna Inc., BioNTech SE, Zydus Lifesciences Limited, CSL Seqirus, Sinovac Biotech Ltd., GC Biopharma corp., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Indian Immunologicals Ltd., Bavarian Nordic, Panacea Biotec Ltd., WestVac Biopharma Co. Ltd., VBI Vaccines Inc.

What are the key trends shaping the future of the multivalent vaccines market?

The primary players in the multivalent vaccines market are concentrating their efforts on creating innovative pentavalent vaccines. The primary aim here is to enhance the overall state of public health through offering wider protection with a single dosage. A multivalent vaccine, or specifically a pentavalent vaccine, aims to protect against five different pathogens or strains. Combining these protections in a singular vaccine makes the immunization schedules less complex and maximizes the coverage of the vaccine. As an example, in December 2023, Panacea Biotec Ltd., established in India, introduced EasyFourPol. This novel vaccine holds the distinction of being the world’s maiden fully liquid vaccine, offering protection against five crucial diseases which include diphtheria, tetanus, whooping cough, polio, and Haemophilus influenzae type B. This ready-made combination vaccine eradicates the necessity of preparation by medical personnel, thus making the vaccination procedure more efficient. At par with single-antigen vaccines in terms of protection level, it reduces the frequency of clinic visits for children and brings down overall costs of immunization. On another front, it not only boosts efficiency in vaccination but also contributes to environmental wellbeing by diminishing the requirement for vials, syringes, and packaging.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19120

What regions are dominating the multivalent vaccines market growth?

North America was the largest region in the multivalent vaccines market in 2024. The regions covered in the multivalent vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Vaccine Contract Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vaccine-contract-manufacturing-global-market-report

DTP Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: